MDPI and ACS Style
Tobajas, Y.; Alemany-Fornés, M.; Samarra, I.; Romero-Giménez, J.; Cuñé-Castellana, J.; Tintoré, M.; del Pino, A.; Canela, N.; del Bas, J.M.; Ortega-Olivé, N.;
et al. Exploring the Relationship between Diamine Oxidase and Psychotropic Medications in Fibromyalgia Treatment, Finding No Reduction in Diamine Oxidase Levels and Activity except with Citalopram. J. Clin. Med. 2024, 13, 792.
https://doi.org/10.3390/jcm13030792
AMA Style
Tobajas Y, Alemany-Fornés M, Samarra I, Romero-Giménez J, Cuñé-Castellana J, Tintoré M, del Pino A, Canela N, del Bas JM, Ortega-Olivé N,
et al. Exploring the Relationship between Diamine Oxidase and Psychotropic Medications in Fibromyalgia Treatment, Finding No Reduction in Diamine Oxidase Levels and Activity except with Citalopram. Journal of Clinical Medicine. 2024; 13(3):792.
https://doi.org/10.3390/jcm13030792
Chicago/Turabian Style
Tobajas, Yaiza, Marc Alemany-Fornés, Iris Samarra, Jordi Romero-Giménez, Jordi Cuñé-Castellana, Maria Tintoré, Antoni del Pino, Núria Canela, Josep M. del Bas, Nà dia Ortega-Olivé,
and et al. 2024. "Exploring the Relationship between Diamine Oxidase and Psychotropic Medications in Fibromyalgia Treatment, Finding No Reduction in Diamine Oxidase Levels and Activity except with Citalopram" Journal of Clinical Medicine 13, no. 3: 792.
https://doi.org/10.3390/jcm13030792
